3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Histologic Type
1
Neoplasms
1
Carcinoma
1
Adenocarcinoma
1
Interventions
Gemcitabine
4
pembrolizumab
3
napabucasin
3
Irinotecan
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
lenvatinib
2
entinostat
2
Taxes
2
Sunitinib
2
Sorafenib
2
Paclitaxel
2
Leucovorin
2
Fluorouracil
2
Cisplatin
2
Bevacizumab
2
pralsetinib
1
linifanib
1
durvalumab
1
Radiofrequency Ablation
1
Pemetrexed
1
Nivolumab
1
Immunotherapy
1
Endoscopic Mucosal Resection
1
Cobicistat
1
Chemoradiotherapy
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Glandular and Epithelial
×
Cobicistat
×
Gastrointestinal
×
Clear all
NCT05494866
2025-03-25
IntenSify
German Cancer Research Center
Phase 1
Terminated
6 enrolled